According to GlobalData’s medical device pipeline database, 38 Thyroid Function Tests devices are in various stages of development globally. GlobalData’s report Thyroid Function Tests provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 15 are in active development, while the remaining 23 are in an inactive stage of development. There are 11 products in the early stages of development, and the remaining four are in the late stages of development.
Thyroid Function Tests (TFTs) are performed to evaluate the function of thyroid gland. TFTs are generally prescribed when a patient is suspected with abnormal level of thyroid hormones. Abnormal level of thyroid hormones in the body can cause either hyperthyroidism (high level of thyroid hormones) or hypothyroidism (low level of thyroid hormones). Evaluation of thyroid function can be done by determining the concentration of thyroid and thyroid related hormones which are thyroxine (T4), triiodothyronine (T3) and thyroid stimulating hormone (TSH). TSH test, FT4 test, TT4 test, FT3 test, TT3 test and Other Thyroid Function test are majorly prescribed quantitative tests for accessing thyroid function. TFTs are prescribed for both diagnosis and monitoring of hyperthyroidism and hypothyroidism. This segment includes sub-segments Thyroid Stimulation Hormone (TSH) Tests, Free Thyroxine (FT4) Tests, Total Thyroxine (TT4) Tests, Free Triiodothyronine (FT3) Tests, Total Triiodothyronine (TT3) Tests and Other Thyroid Function Tests.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Thyroid Function Tests pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Thyroid Function Tests devices. Overall, most of these Thyroid Function Tests pipeline devices are being developed by private entities.
Key players involved in the active development of Thyroid Function Tests include GeneFluidics, Guangzhou Wondfo Biotech, Roche Diagnostics International, Siemens Healthcare Diagnostics, Sysmex, SpinChip Diagnostics, Abionic, Mediomics, MedMira and Novartis.
For a complete picture of the developmental pipeline for Thyroid Function Tests devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.